EUA may be granted to any drug following a positive Phase II. I hope for both outcomes. Regardless of achieving a long-shot EUA, should Brilacidin achieve good Phase II results, a Phase III trial will be necessary.
I hope Innovation Pharmaceuticals pursues every option to gain funding for Phase III. The EU program may be one good funding option.